Why partner with MS Pharma?
In a region with fast-paced changes and challenges, MS Pharma has remained true to its reputation of quality and high performance. A company does not form and hone partnerships overnight, which is why MS Pharma’s partners can rely on the strong foundation that we have created over the years, leading to various productive and efficient deals.
With 414 products on the market, 480 products in pipeline, and operations in more than 16 countries (in the Middle East, Turkey, and Africa), our accomplishments are not ones we take lightly; we’re always striving for excellence and constantly strengthening our body of work – which is what our partners and suppliers have come to expect from MS Pharma.
Through our recognized, highly regarded efforts, we were able to tap into difficult markets such as Algeria through our durable infrastructure and assets, as well as expand our business entities to various countries that allow us complete access and facilitated dealings all over the region.
What is our business approach?
Our partners are our source of guidance; we tailor-make a deal with associates regarding their individual market specifications, because we know there’s more to a contract than merely supply and demand. Every request and query is met with a detailed answer and efficient response time.
Through In-house Development, we can formulate a product that meets every requirement specification, because our pharmacists are always kept abreast in developments in drug research, therefore our intellect is always up-to-date and dependable.
Out-licensing is another aspect of our business model, whereby we offer a wide variety of well-developed dossiers and many complying with EU formats are available .. Our partners can rest knowing we have the tools and capacity to evaluate the right entity to pursue, leading to profitable margins and positive outcomes.
Also, at MS Pharma we are looking for new business partners and suppliers in the field of research and development via In-lisencing business model. We are also open to new ideas and collaboration with other companies in our industry either for co-development, technology transfer or finished formulations supply.
In addition, we employ the use of the following collaboration models:
- Green Fields
- Mergers and acquisitions
- BOT (Build, Operate, Transfer)
- Toll manufacturing at and for third parties
- In-licensing via technology transfer